Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Hyperpolarized Magnetic Resonance at the point-of-care

Project description

NMR solution for real-time monitoring and point-of-care analyses

Nuclear magnetic resonance (NMR) is a powerful analytical method in medical imaging, structural biology, and chemical analysis. While it offers flexibility, its sensitivity limitations mean it cannot detect low-concentration compounds in biological samples of urine, blood, and saliva. The ERC-funded HYPMET project aims to develop new technology to detect body fluid metabolites below current NMR levels. It will enable real-time monitoring of key metabolic pathways in cells and in vivo, support personalised medical treatments, and facilitate NMR metabolomics analyses at the point of care without the need for superconducting magnets. This solution will pave the way for significant advancements in NMR metabolomics.

Objective

HYPMET proposes a pioneering research methodology for hyperpolarized magnetic resonance for real-time monitoring of upregulated metabolic pathways in cancer cells and in-vivo and for body fluid metabolic analyses with the prospect of revolutionizing the medical approach to personalised treatments.
A common analytical method for structural biology, medical imaging, and chemical analysis is nuclear magnetic resonance (NMR), which is flexible but intrinsically insensitive. Even in the most sensitive NMR spectra, many endogenous compounds found in blood, saliva, or urine are currently unresolved.
HYPMET will establish a ground-breaking technology enabling the detection of body fluids metabolites below the current limit of NMR detection (~μM) and the real-time monitoring of clinically relevant metabolic pathways in-cells and in-vivo; it will enable NMR metabolomics analyses at the point-of-care and will be fully compatible with personalised medical treatments; it will be compact (less than 10×10×30 cm) and will not require superconducting magnets.
Emerging methods (e.g. hyperpolarisation methods - HM) can boost the NMR signal intensity. HYPMET will merge two HMs to achieve NMR signal enhancements of several thousand-fold continuously, in the liquid state and at ultra-low-magnetic field (ULF, i.e. <10 mT) for many nuclear isotopes. The two HMs are: Overhauser Dynamic Nuclear Polarization (ODNP) and Signal Amplification By Reversible Exchange (SABRE). The PI unique expertise spans method development on various HMs and development and implementation of a protocol for real-time monitoring of pyruvate to lactate conversions in-cells and in-vivo to probe the state of a tumor in real-time. Success in this multidisciplinary project will pave the way for efficient NMR metabolomics analyses and for better real-time metabolic conversion monitoring directly at the point-of-care. In the future, the technology could be further reduced in size and become a widespread clinical tool.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-STG

See all projects funded under this call

Host institution

UNIVERSITA DEGLI STUDI DI PADOVA
Net EU contribution
€ 1 499 968,75
Address
VIA 8 FEBBRAIO 2
35122 Padova
Italy
Region
Nord-Est Veneto Padova
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 968,75

Beneficiaries (1)